Anticoagulation challenges in cancer patients: prevention, detection, and treatment strategies [0.03%]
癌症患者的抗凝挑战：预防、检测和治疗策略
Simona Chiusolo,Chelsea Kriesberg,Eric Oligino et al.
Simona Chiusolo et al.
The state of cardio-oncology in Oman: awareness, practices, and training needs among healthcare providers: a survey-based study [0.03%]
阿曼心血管肿瘤学的现状：医疗保健提供者对意识、实践和培训需求的调查研究
Ahmed Basuoni,Bushra Salman,Khalid Al-Baimani et al.
Ahmed Basuoni et al.
Entrectinib results in ventricular tachycardia and Brugada phenocopy through inhibition of sodium current [0.03%]
ENTRECTINIB 通过抑制钠电流导致室性心动过速和Brugada综合征样表现
Matthew R Fleming,Tao Yang,John A Wells et al.
Matthew R Fleming et al.
Background: Entrectinib is a tropomyosin receptor kinase (TrK) inhibitor currently approved for the treatment of ROS1-positive non-small cell lung cancer (NSCLC) and neurotrophic tyrosine receptor kinase (NTRK) gene fusio...
Sacubitril/valsartan for the prevention of cancer therapy-related cardiac dysfunction: a systematic review and meta-analysis [0.03%]
萨库布维林/缬沙坦预防癌症治疗相关性心功能障碍的系统评价和meta分析
Yee-Jen Wu,Hung-Ju Lin,Yi-Hsin Hung et al.
Yee-Jen Wu et al.
Evaluating the impact of Lutetium-177 therapy on bioprosthetic heart valves in carcinoid heart disease [0.03%]
lutetium-177核素治疗对类癌心脏病生物心脏瓣膜影响的评估
Isabel G Scalia,Fatmaelzahraa E Abdelfattah,Juan M Farina et al.
Isabel G Scalia et al.
Chemotherapy-responsive primary cardiac lymphoma presenting as pericarditis and acute heart failure [0.03%]
以心包炎和急性心力衰竭形式表现的化疗敏感型原发心脏淋巴瘤
Meghan Schilthuis,Benjamin Fischer,Shanelle De Lancy et al.
Meghan Schilthuis et al.
Disease burden of ATTR amyloidosis based on the SF-36® health survey [0.03%]
基于SF-36健康调查表的ATTR淀粉样变病疾病负担研究
Vaishali Sanchorawala,Alexandra Greatsinger,Andrew Staron et al.
Vaishali Sanchorawala et al.
Transthyretin (ATTR) amyloidosis is a progressive systemic disease associated with substantial morbidity and mortality. Although health-related quality of life (HRQoL) assessments are increasingly incorporated into clinical trials, data in ...
Exploring healthcare professionals' experiences and perceptions of self-management of cancer therapy-induced cardiotoxicity in breast cancer survivors: a qualitative study [0.03%]
探索医护人员对乳腺癌幸存者癌症治疗诱发的心脏毒性自我管理的经验和看法：一项定性研究
Xianliang Liu,Mubei Yang,Yuhua Ma et al.
Xianliang Liu et al.
The pulmonary artery hypertension and cancer: PULAHYCA PILOT study. Initial prostanoid therapy in cancer patients with pulmonary hypertension: results from an observational study [0.03%]
肺动脉高血压与癌症：PULAHYCA PILOT研究。一项观察性研究的结果：癌性肺动脉高压患者初始前列环素类药物治疗
Vanesa Gregorietti,Teresa López-Fernández,Joerg Herrmann et al.
Vanesa Gregorietti et al.
Review on cardioprotective strategies in the setting of chemotherapy-induced cardiotoxicity [0.03%]
化疗诱导的心脏毒性的缺血修饰红细胞心脏保护策略研究进展
Vinh Dao,Shray Amin,Thirumala Kammaripalle et al.
Vinh Dao et al.